Product NDC: | 10019-510 |
Proprietary Name: | Diltiazem Hydrochloride |
Non Proprietary Name: | Diltiazem Hydrochloride |
Active Ingredient(s): | 5 mg/mL & nbsp; Diltiazem Hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10019-510 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078538 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100713 |
Package NDC: | 10019-510-01 |
Package Description: | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-510-01) > 5 mL in 1 VIAL, SINGLE-DOSE (10019-510-79) |
NDC Code | 10019-510-01 |
Proprietary Name | Diltiazem Hydrochloride |
Package Description | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-510-01) > 5 mL in 1 VIAL, SINGLE-DOSE (10019-510-79) |
Product NDC | 10019-510 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Diltiazem Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20100713 |
Marketing Category Name | ANDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | DILTIAZEM HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |